Cited 0 times in
Strategy for Hepatitis C Treatment in Liver Transplant Settings
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 박준용 | - |
dc.date.accessioned | 2017-10-26T08:03:15Z | - |
dc.date.available | 2017-10-26T08:03:15Z | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 1298-1711 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/152880 | - |
dc.description.abstract | In patients with detectable virus at the time of liver transplantation, hepatitis C virus (HCV) infection always recurs on the graft, and 30% of patients have an aggressive clinical and histologic course with increased morbidity, mortality, and graft loss. Moreover, in some transplantation patients, recurrent HCV infection leads to an aggressive course of disease known as fibrosing cholestatic hepatitis, which is characterized by hepatic decompensation and death. Liver allograft and recipient survival can be substantially improved with successful eradication of HCV. Recent advances in direct-acting antiviral agents have revolutionized the management of HCV infection, and a number of these agents have shown high sustained virological responses, shorter durations of treatment, and much improved tolerability when compared with previous pegylated interferon based therapies in liver transplant settings. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | Journal of the Korean Society for Transplantation | - |
dc.publisher | Journal of the Korean Society for Transplantation | - |
dc.relation.isPartOf | Journal of the Korean Society for Transplantation | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.title | Strategy for Hepatitis C Treatment in Liver Transplant Settings | - |
dc.type | Article | - |
dc.publisher.location | Korea | - |
dc.contributor.college | College of Medicine | - |
dc.contributor.department | Dept. of Internal Medicine | - |
dc.contributor.googleauthor | Jun Yong Park | - |
dc.identifier.doi | 10.4285/jkstn.2016.30.4.149 | - |
dc.contributor.localId | A01675 | - |
dc.relation.journalcode | J01858 | - |
dc.identifier.eissn | 2508-2604 | - |
dc.contributor.alternativeName | Park, Jun Yong | - |
dc.contributor.affiliatedAuthor | Park, Jun Yong | - |
dc.citation.volume | 30 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 149 | - |
dc.citation.endPage | 154 | - |
dc.identifier.bibliographicCitation | Journal of the Korean Society for Transplantation, Vol.30(4) : 149-154, 2016 | - |
dc.date.modified | 2017-10-24 | - |
dc.identifier.rimsid | 40505 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.